Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SCYNEXIS Inc (SCYX)
:SCYX
Holding SCYX?
Track your performance easily
SCYX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.90 - $3.07
Previous CloseN/A
Volume100.07K
Average Volume (3M)281.42K
Market Cap
$43.26M
Enterprise Value$19.08M
Total Cash (Recent Filing)$58.59M
Total Debt (Recent Filing)$14.25M
Price to Earnings (P/E)―
Beta2.69
Next Earnings
Mar 26, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding37,948,990
10 Day Avg. Volume237,509
30 Day Avg. Volume281,416
Standard Deviation0.23
R-Squared0.12
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.05
Price to Cash Flow (P/CF)14.10
P/FCF Ratio14.10
Enterprise Value/Market Cap0.44
Enterprise Value/Revenue4.21
Enterprise Value/Gross Profit0.15
Enterprise Value/Ebitda-1.17
Forecast
1Y Price Target
$8.00Price Target Upside614.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
SCYNEXIS News
PremiumPre-Earnings
Is SCYX a Buy, Before Earnings?
PremiumCompany Announcements
SCYNEXIS Advances Antifungal Treatments, Strengthens Financial Outlook
Ownership Overview
3.42% Insiders
24.14% Mutual Funds
0.04% Other Institutional Investors
56.35% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SCYX FAQ
What was SCYNEXIS Inc’s price range in the past 12 months?
SCYNEXIS Inc lowest stock price was $0.90 and its highest was $3.07 in the past 12 months.
What is SCYNEXIS Inc’s market cap?
SCYNEXIS Inc’s market cap is $43.26M.
When is SCYNEXIS Inc’s upcoming earnings report date?
SCYNEXIS Inc’s upcoming earnings report date is Mar 26, 2025 which is in 65 days.
How were SCYNEXIS Inc’s earnings last quarter?
SCYNEXIS Inc released its earnings results on Nov 06, 2024. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.143 by $0.083.
Is SCYNEXIS Inc overvalued?
According to Wall Street analysts SCYNEXIS Inc’s price is currently Undervalued.
Does SCYNEXIS Inc pay dividends?
SCYNEXIS Inc does not currently pay dividends.
What is SCYNEXIS Inc’s EPS estimate?
SCYNEXIS Inc’s EPS estimate is -0.02.
How many shares outstanding does SCYNEXIS Inc have?
SCYNEXIS Inc has 37,948,990 shares outstanding.
What happened to SCYNEXIS Inc’s price movement after its last earnings report?
SCYNEXIS Inc reported an EPS of -$0.06 in its last earnings report, beating expectations of -$0.143. Following the earnings report the stock price went up 0.758%.
Which hedge fund is a major shareholder of SCYNEXIS Inc?
Currently, no hedge funds are holding shares in SCYX
---
SCYNEXIS Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (614.29% Upside)
$8.00 (614.29% Upside)
Blogger Sentiment
Bullish
SCYX Sentiment 70%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 4.0%
Last 30 Days ▲ 4.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.10%
12-Months-Change
Fundamentals
Return on Equity
-48.42%
Trailing 12-Months
Asset Growth
-33.33%
Trailing 12-Months
Company Description
SCYNEXIS Inc
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
---
SCYX Company Deck
---
SCYX Earnings Call
Q4 2023
0:00 / 0:00
---
SCYX Stock 12 Month Forecast
Average Price Target
$8.00
▲(614.29% Upside)
Technical Analysis
Chimerix
―
Karyopharm Therapeutics
―
Adaptimmune Therapeutics
―
ADMA Biologics
―
Inovio Pharmaceuticals
―
Sorrento Therapeutics
―
Best Analysts Covering SCYX
1 Year
1 Year Success Rate
5/38 ratings generated profit
1 Year Average Return
-26.36%
reiterated a buy rating 5 months ago
Copying Michael Higgins's trades and holding each position for 1 Year would result in 13.16% of your transactions generating a profit, with an average return of -26.36% per trade.
---